Key result
The estimated seroprevalence of Aujeszky's disease virus in Swiss wild boar was 0.57%, representing a significant decrease from the 2.83% prevalence observed in 2004-2005.
Cross-Sectional (n=1,228)
Yes
Absolute Event Rate: 0.57% vs 2.83%
p-value: p=<0.001
The seroprevalence of Aujeszky's disease virus in wild boar in Switzerland is among the lowest documented in Europe (0.57%), suggesting factors beyond animal density, such as stress and management, influence infection dynamics.
Low ADV seroprevalence persists in Swiss wild boar despite rising densities; leaves open the role of management and stress factors in European patterns.
BACKGROUND: In parallel to the increase of wild boar abundance in the past decades, an increase of exposure to the Aujeszky's disease virus (ADV) has been reported in wild boar in several parts of Europe. Since high animal densities have been proposed to be one of the major factors influencing ADV seroprevalence in wild boar populations and wild boar abundance has increased in Switzerland, too, a re-evaluation of the ADV status was required in wild boar in Switzerland. We tested wild boar sera collected from 2008-2013 with a commercial ELISA for antibodies against ADV. To set our data in the European context, we reviewed scientific publications on ADV serosurveys in Europe for two time periods (1995-2007 and 2008-2014). RESULTS: Seven out of 1,228 wild boar sera were positive for antibodies against ADV, resulting in an estimated seroprevalence of 0.57% (95% confidence interval CI: 0.32-0.96%). This is significantly lower than the prevalence of a previous survey in 2004-2005. The literature review revealed that high to very high ADV seroprevalences are reported from Mediterranean and Central-eastern countries. By contrast, an "island" of low to medium seroprevalences is observed in the centre of Europe with few isolated foci of high seroprevalences. We were unable to identify a general temporal trend of ADV seroprevalence at European scale. CONCLUSIONS: The seroprevalence of ADV in wild boar in Switzerland belongs among the lowest documented in Europe. Considering the disparity of seroprevalences in wild boar in Europe, the fact that seroprevalences in Switzerland and other countries have decreased despite increasing wild boar densities and the knowledge that stress leads to the reactivation of latent ADV with subsequent excretion and transmission, we hypothesize that not only animal density but a range of factors leading to stress - such as management - might play a crucial role in the dynamics of ADV infections.
No takes yet. Share an insight, caveat, or question.
Meier et al. (2015) conducted a cross-sectional in Aujeszky's disease virus (ADV) exposure (n=1,228). Time period 2008-2013 vs. Time period 2004-2005 was evaluated on ADV seroprevalence (95% CI 0.32-0.96, p=<0.001). The estimated seroprevalence of Aujeszky's disease virus in Swiss wild boar was 0.57%, representing a significant decrease from the 2.83% prevalence observed in 2004-2005.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: